2000
DOI: 10.1067/mtc.2000.108931
|View full text |Cite
|
Sign up to set email alerts
|

Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy

Abstract: In selected patients with idiopathic dilated cardiomyopathy, lasting recovery can be achieved after unloading with a left ventricular assist device. Lasting cardiac recovery seems to be related to functional normalization and a more rapid recovery during the unloading period.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
39
0
3

Year Published

2002
2002
2023
2023

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 89 publications
(43 citation statements)
references
References 14 publications
1
39
0
3
Order By: Relevance
“…As described previously, not all patients may recover sufficient ventricular strength to allow weaning from their LVAD 8 -12 and prolonged recovery of their myocardial contractile function. 21 In the present study, failing hearts required 1 month of unloading after a large LV infarction before we were able to measure functional improvement. In contrast, failing hearts that received intracoronary Adv-␤ 2 AR demonstrated significant LV functional improvement within the first week of ventricular unloading.…”
Section: Discussionmentioning
confidence: 99%
“…As described previously, not all patients may recover sufficient ventricular strength to allow weaning from their LVAD 8 -12 and prolonged recovery of their myocardial contractile function. 21 In the present study, failing hearts required 1 month of unloading after a large LV infarction before we were able to measure functional improvement. In contrast, failing hearts that received intracoronary Adv-␤ 2 AR demonstrated significant LV functional improvement within the first week of ventricular unloading.…”
Section: Discussionmentioning
confidence: 99%
“…In prior retrospective clinical studies, the frequency of cardiac recovery and device explantation has varied. 9,12,22 Recent reports from the Harefield Hospital (UK) describe the use of clenbuterol, an oral ␤ 2 agonist, in combination with an aggressive pharmacological regimen consisting of lisinopril, carvediol, spironolactone, and losartan in LVAD patients to enhance myocardial recovery. 23 With this approach, 11 of 15 dilated cardiomyopathy patients (73%) demonstrated cardiac recovery sufficient to undergo successful device explantation, with 100% and 89% cumulative rates of freedom from recurrent HF at 1 and 4 years, respectively.…”
Section: Recoverymentioning
confidence: 99%
“…Unloading of failing rodent hearts by heterotopic transplantation 29 and failing human hearts by LVAD has the potential to contribute to functional recovery. 3,4 Mechanical LVAD unloading in a subset of patients with heart failure can improve dysregulated cardiac gene expression 3,4,30,31 as well as contractile properties and [Ca 2ϩ ] i handling. 32,33 It is speculated that cardiac unloading by LVAD for a very long duration in heart failure patients may result in partial cardiac atrophy and depressed contractile performance.…”
Section: Implications For Humans With Excess Cardiac Unloadingmentioning
confidence: 99%
“…1,2 Mechanical unloading of failing human hearts with LV-assist devices (LVADs) reduces excess LV load and mass and improves cardiac performance in some patients. 3,4 However, the effect of severe and chronic unloading of the normal heart on myocyte contractile function is unclear.…”
mentioning
confidence: 99%